Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Sham Operation

Research Leaders

20 sponsors active, led by University Hospital, Basel, Switzerland

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 11 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 4 (1)

Trial Status

Completed5
Recruiting3
Unknown2
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (11)

Research Network

Common Treatments

  • Sham Operation1
  • Dynamic Contrast Enhanced Computerised Tomography1
  • Lactate Dehydrogenase1
  • Heparin1
  • Bms Vs Cs1

Active Sponsors

  • University Hospital, Basel, Switzerland1
  • Assiut University1
  • Poitiers University Hospital1
  • Clarunis - Universitäres Bauchzentrum Basel1
  • Techmed University of Twente1

Top Investigators

Related Conditions

  • Celiac Artery Compression Syndrome1
  • Colorectal Cancer1
  • Crohn Disease1
  • Stentgraft Thrombosis1
  • Acute Kidney Injury1

Activity Timeline